Gino Baumann

Making improvements in life possible is more than our vision. It is the reason QIAGEN exists. From combating cancer and diagnosing infectious diseases to keeping food and communities safe, the world's most urgent challenges begin with unlocking the insights hidden in DNA and RNA, the building blocks of life. That is where we come in. We are QIAGEN, a Netherlands-based global leader in Sample to Insight solutions. Our technologies isolate and process DNA, RNA and proteins, prepare them for analysis, and turn complex molecular data into clear, actionable insights. Automation brings it together into seamless workflows for the Life Sciences (academia, pharmaceutical R&D and industrial applications such as forensics) and Molecular Diagnostics for clinical healthcare. Every day, more than 500,000 customers around the world rely on us to extract meaning from genetic material quickly, confidently and accurately, from young scientists and pharma R&D teams to clinical labs and more than 35 Nobel Prize winners. Behind it all are the QIAGENers, more than 5,000 colleagues across 75 nationalities and subsidiaries in 25 countries, united by the three promises in our name: Quality, Ingenuity and Accessibility. We are a partner in progress, backed by a deep commitment to science and better healthcare. That commitment extends beyond the lab to how we operate, including our goal of reaching net zero by 2050. NYSE: QGEN | Frankfurt Prime Standard: QIA Learn more at www.qiagen.com